首页 > 抗体蛋白 > 抗体
FITC anti-human CD20 Antibody
产品名称:
FITC anti-human CD20 Antibody
产品类别:
抗体
产品编号:
302303
产品应用:
302303
[价格]
规格 价格 库存
25tests ¥ 660 1

产品详情

Product Details

Verified Reactivity
Human, Cynomolgus, Rhesus
Reported Reactivity
Baboon, Capuchin Monkey, Chimpanzee, Pigtailed Macaque, Squirrel Monkey
Antibody Type
Monoclonal
Host Species
Mouse
Immunogen
Human tonsillar B cells
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and BSA (origin USA)
Preparation
The antibody was purified by affinity chromatography, and conjugated with FITC under optimal conditions.
Concentration
Lot-specific (to obtain lot-specific concentration, please enter the lot number in our Concentration and Expiration Lookup or Certificate of Analysis online tools.)
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested

Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is 5 ?l per million cells in 100 ?l staining volume or 5 ?l per 100 ?l of whole blood.

Excitation Laser
Blue Laser (488 nm)
Application Notes

The epitope recognized by clone 2H7 has been mapped to the sequence YNCEPANPSEKNSPST which lies in the large extracellular loop of human CD20. Additional reported applications (for the relevant formats) include: immunoprecipitation4 and immunohistochemical staining of acetone-fixed frozen sections5.

Application References

(PubMed link indicates BioLegend citation)
  1. Schlossman S, et al. 1995. Leucocyte Typing V. Oxford University Press. New York.
  2. Knapp W, et al. 1989. Leucocyte Typing IV. Oxford University Press. New York.
  3. McMichael A, et al. Eds. 1987. Leucocyte Typing III Oxford University Press. New York.
  4. Polyak MJ, et al. 2002. Blood 99:3256. (IP)
  5. Mack CL, et al. 2004. Pediatr. Res. 56:79. (IHC)
Product Citations
  1. Qiu J, et al. 2020. Cell Rep. 33:108465. PubMed
  2. Rosa TLSA, et al. 2022. Front Med (Lausanne). 9:899998. PubMed
  3. Serra–Peinado C, et al. 2019. Nat Commun. 10:3705. PubMed
  4. Hagan T, et al. 2020. Cell. 178(6):1313-1328.e13.. PubMed
  5. Hasaart KAL, et al. 2020. Sci Rep. 10:12991. PubMed
  6. Laustsen A, et al. 2021. Elife. 10:. PubMed
  7. Panwar B, et al. 2021. Genome Res. 31:659. PubMed
  8. Kobayashi Y, et al. 2020. Int J Oncol. 999:56. PubMed
  9. Cao Y, et al. 2022. Nature. :. PubMed
  10. Lin JR et al. 2018. eLife. 7 pii: e31657. PubMed
  11. Appios A, et al. 2021. Bio Protoc. 11:e4044. PubMed
  12. Cao Y, et al. 2022. Nature. 602:657. PubMed
  13. Lewis SA, et al. 2021. Front Immunol. 12:724015. PubMed
  14. Izmirly AM, et al. 2022. PLoS Pathog. 18:e1009903. PubMed
  15. Song TZ, et al. 2021. Front Endocrinol (Lausanne). 12:745984. PubMed
  16. Sureshchandra S, et al. 2022. Cell Rep. 39:110938. PubMed
  17. Janela B, et al. 2019. Immunity. 50:1069. PubMed
  18. Krishnan S, et al. 2021. Clin Exp Immunol. 203:458. PubMed
  19. Lu J, et al. 2021. Front Immunol. 12:732612. PubMed
  20. Paidi SK, et al. 2021. Biosens Bioelectron. 190:113403. PubMed
  21. Louka E, et al. 2021. Journal of Experimental Medicine. 218(2):. PubMed
  22. Rodriguez-Meira A, et al. 2020. STAR Protoc. 1:100125. PubMed
  23. Mishra A, et al. 2021. Cell. 184(13):3394-3409.e20. PubMed
  24. Wong GK, et al. 2019. JCI Insight. 4. PubMed
  25. Bradley D, et al. 2022. Nat Commun. 13:5606. PubMed
  26. Saber MM, et al. 2022. Antibodies (Basel). 11:. PubMed
  27. Hu Q, et al. 2021. Nat Commun. 12:2186. PubMed
  28. Danzer H, et al. 2020. Elife. 9:00. PubMed
  29. Buters TP, et al. 2021. Br J Clin Pharmacol. Online ahead of print. PubMed
  30. Foote JR, et al. 2019. Front Immunol. 10:188. PubMed
  31. Beyer AI, et al. 2017. Stem Cells Dev. 26:102. PubMed
  32. Vanoni G, et al. 2021. eLife. 10:00. PubMed
  33. Martin GE, et al. 2018. Front Immunol. 1.019444444. PubMed
  34. Rodriguez‐Meira A et al. 2019. Molecular cell. 73(6):1292-1305 . PubMed
RRID
AB_314251 (BioLegend Cat. No. 302303) AB_314252 (BioLegend Cat. No. 302304)

Antigen Details

Structure
Four transmembrane protein (TM4SF), heavily phosphorylated after activation, 33-37 kD
Distribution

B cell, T cell subsets

Function
B cell activation
Ligand/Receptor
Src family tyrosine kinases, MHC class I, II, CD53, CD81, CD82
Cell Type
B cells, T cells
Biology Area
Costimulatory Molecules, Immunology
Molecular Family
CD Molecules
Antigen References

1. Hultin L, et al. 1993. Cytometry 14:196.
2. Tedder T, et al. 1994. Immunol. Today 15:450.

Gene ID
931 View all products for this Gene ID
UniProt
View information about CD20 on UniProt.org

联系我们

TEL:021-34661275  点击拨打热线